|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
PharmaSwiss D.O.O.
Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name PharmaSwiss D.O.O. Beograd Headquarters Vojvode Stepe 18; Belgrade; Belgrade; 11000 |
Status: Non-Listed Legal Form: Limited Liability Company Operational Status: Operational YU-MB: 17338480 Financial Auditors: Deloitte Touche Tohmatsu (2010) Incorporation Date: May 10, 2001 Total Employees: 294 Tel: (+381 11) 3093900 |
|
Company Description |
| Swiss pharmaceutical company PharmaSwiss set up its Serbian unit in 2001. The Belgrade-based company is active in the wholesale and manufacture of pharmaceuticals and pharmaceutical products. It is an exclusive distributor and representative of Bristol Myers Squib, Ibsen, Wyeth-embrel, Reckitt Benckiser, Amgen, Astelas, Aspen, Lannacher, Mika Pharma and Eli Lilly. |
Key Executives |
|
|||||
|
|||||
|
FULL COMPANY PROFILE
|
|
2011 Y (non-cons) |
2010 Y (non-cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
XXX |
XXX |
| ||
Current Assets |
XXX |
XXX |
| ||
Total Liabilities |
XXX |
XXX |
| ||
Shareholders Equity |
XXX |
XXX |
| ||
Current Liabilities |
XXX |
XXX |
| ||
| * All the accounts are in RSD. | ||
Income Statement
| ||
Total Operating Revenue |
XXX |
XXX |
| ||
Operational Profit (Loss) |
XXX |
XXX |
| ||
Net Profit (Loss) |
XXX |
XXX |
| ||
| * All the accounts are in RSD. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
XXX |
XXX |
| ||
Annualised Return on Assets (ROA) |
XXX |
XXX |
| ||
Return on Equity (ROE) |
XXX |
XXX |
| ||
Annualised Return on Equity (ROE) |
XXX |
XXX |
| ||
Return on Sales (ROS) |
XXX |
XXX |
| ||
Return on Capital |
XXX |
XXX |
| ||
Gross Profit Margin |
XXX |
XXX |
| ||
Operating Profit Margin |
XXX |
XXX |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
XXX |
XXX |
| ||
Inventory Turnover |
XXX |
XXX |
| ||
Current asset turnover |
XXX |
XXX |
| ||
Fixed-asset turnover |
XXX |
XXX |
| ||
Asset Turnover |
XXX |
XXX |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
XXX |
XXX |
| ||
EBITDA |
XXX |
XXX |
| ||
Bookvalue (BV) |
XXX |
XXX |
| ||
Net Cash |
XXX |
XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XXX |
XXX |
| ||
Quick ratio |
XXX |
XXX |
| ||
Doom's day ratio |
XXX |
XXX |
| Leverage Ratios | ||
| ||
Leverage ratio |
XXX |
XXX |
| ||
Debt to equity |
XXX |
XXX |
| ||
Debt to total assets |
XXX |
XXX |
| ||
Long Term Debt to Capital |
XXX |
XXX |
| Trend Ratios | ||
| ||
Revenue Trend |
XXX |
XXX |
| ||
Net Income Trend |
XXX |
XXX |
| ||
Operating Income Trend |
XXX |
XXX |
| ||
 |